Progress in the treatment of aggressive B-cell non-Hodgkin lymphoma
10.3760/cma.j.issn.1009-9921.2018.10.001
- VernacularTitle:侵袭性B细胞非霍奇金淋巴瘤治疗进展
- Author:
Donglu ZHAO
1
;
Jun MA
Author Information
1. 150010,哈尔滨血液病肿瘤研究所
- Keywords:
Aggressive B-cell non-Hodgkin lymphoma;
Chimeric antigen receptor T-cell immunotherapy;
Immunotargeted therapy
- From:
Journal of Leukemia & Lymphoma
2018;27(10):577-580,590
- CountryChina
- Language:Chinese
-
Abstract:
The 23rd Congress of the European Hematology Association (EHA) was held in Stockholm, Sweden from June 14-17, 2018. The latest analysis of three chimeric antigen receptor T-cell treatments for diffuse large B-cell lymphoma and clinical data from a number of immunotargeting drugs were presented at this congress, all showing encouraging results. The recent progress of aggressive B-cell non-Hodgkin lymphoma is briefly introduced in this paper.
